Concepedia

Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trials

Mark T. Dransfield, Jean Bourbeau, Paul Jones, Nicola A. Hanania, Donald A. Mahler, Jørgen Vestbo, Andrew Wachtel, Fernando J. Martínez, Frank Barnhart, Lisa Sanford,

The Lancet Respiratory Medicine · 2013 · 359 citations · 32 references

DOI

Concepts

References

32

Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper

Bartolomé R. Celli, William MacNee, Àlvar Agustí et al. · European Respiratory Journal · 2004 · 4.4K citations · Full text

, , +13

Spirometric Reference Values from a Sample of the General U.S. Population

John Hankinson, John Odencrantz, Kathleen B. Fedan · American Journal of Respiratory and Critical Care Medicine · 1999 · 4.3K citations

, , +16

Salmeterol and Fluticasone Propionate and Survival in Chronic Obstructive Pulmonary Disease

Peter Calverley, Julie A. Anderson, Bartolomé R. Celli et al. · New England Journal of Medicine · 2007 · 3.3K citations · Full text

, , +1

Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease

John R. Hurst, Jørgen Vestbo, Antonio Anzueto et al. · New England Journal of Medicine · 2010 · 3K citations · Full text

, , +14

A 4-Year Trial of Tiotropium in Chronic Obstructive Pulmonary Disease

Donald P. Tashkin, Bartolomé R. Celli, Stephen Senn et al. · New England Journal of Medicine · 2008 · 2.2K citations · Full text

, , +17